Article Information
vol. 8 no. 2
Published By
Online ISSN
History
- Received February 15, 2022
- Accepted March 12, 2022
- Published online May 3, 2022.
Article Versions
- previous version (March 31, 2022 - 08:25).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Theodoros Karampitsakos1,
- Ourania Papaioannou1,
- Ilias Dimeas2,
- Panagiota Tsiri1,
- Vasilina Sotiropoulou1,
- Ioannis Tomos3,
- Ilias C. Papanikolaou4,
- Matthaios Katsaras1,
- Paraskevi Kirgou2,
- Zoe Daniil2,
- Konstantinos I. Gourgoulianis2,
- Fotios Sampsonas1,
- Effrosyni Manali3,
- Spyridon Papiris3,
- Demosthenes Bouros5 and
- Argyris Tzouvelekis1⇑
- 1Dept of Respiratory Medicine, University Hospital of Patras, Patras, Greece
- 2Dept of Respiratory Medicine, Medical School, University of Thessaly, Larissa, Greece
- 32nd Pulmonary Medicine Dept, ATTIKON University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece
- 4Respiratory Medicine Dept, Corfu General Hospital, Corfu, Greece
- 5First Academic Dept of Pneumonology, Hospital for Thoracic Diseases, SOTIRIA, Medical School, National and Kapodistrian University of Athens, Athens, Greece
- Argyris Tzouvelekis (argyris.tzouvelekis{at}gmail.com)
Article usage
Altmetrics
Vol 8 Issue 2
Table of Contents
Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis
